Prediction of progression-free and overall survival following temozolomide chemoradiation using FET PET-based parameters including radiomics in patients with glioblastoma.

Neurooncol Adv · 2025 · PMC12458579 · PMID 41000272

Europe PMC DOI

hedged sentence

0.0020

closest p · 0.0× alpha

0.0020

boldest claim

The sentences

highly significantP = .002actually significant

Furthermore, the radiomics feature original_glcm_Idmn remained statistically significant regarding PFS in both groups ( P < .013) and showed a highly significant association with OS in the methylated group (13.1 vs. 32.8 months, P = .002).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.